1. Home
  2. Browse Decisions
  3. F.Supp.
  4. 830 F.Supp.
  5. 830 F.Supp. 871 (1993)
 

GLAXO, INC. v. NOVOPHARM LTD.

No. 91-759-CIV-5-BO.

830 F.Supp. 871 (1993)

GLAXO, INC. and Glaxo Group Limited, Plaintiffs, v. NOVOPHARM LTD., Defendant.

United States District Court, E.D. North Carolina, Raleigh Division.

September 17, 1993.

Attorney(s) appearing for the Case

Stephen B. Judlowe, William G. Todd, Janet B. Linn, Hopgood, Calimafde, Kalil, Blastein & Judlowe, New York City, Steven P. Lockman, Stuart J. Land, Arnold & Porter, Washington, DC, Joseph W. Eason, Moore & Van Allen, Raleigh, NC, for plaintiffs.

John E. Rosenquist, Robert F. Green, Jeffrey S. Ward, Leydig, Voit & Mayer, Chicago, IL, John R. Wallace, Kirby, Wallace, Creech, Sarda & Zaytoun, Raleigh, NC, for defendant.

ORDER

TERRENCE WILLIAM BOYLE, District Judge.

Plaintiff Glaxo Group Ltd. is the owner of United States Patent No. 4,521,431 covering a particular crystalline form of a chemical compound called ranitidine hydrochloride.1 The '431 patent expires in 2002. Plaintiff Glaxo Inc. is the United States subsidiary of Glaxo Group Ltd. and is the exclusive U.S. licensee of the '431 patent. Defendant...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases